Skip to main content
Intensive Care Medicine Experimental
Fig. 4 | Intensive Care Medicine Experimental

Fig. 4

From: Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trial

Fig. 4

Subgroup I and II. A Selenium treatment (blue) increased serum selenium and selenoprotein P (SELENOP) but not glutathione peroxidase 3 (GPx3) activity in patients with normal kidney function according to the KDIGO definition (I). B Selenium supplementation in patients with reduced renal function led to an increase in serum selenium, SELENOP and GPx3 at Day 4 (II). Gray coloration indicates values below the lower reference limit (selenium and SELENOP) and above the upper reference limit (GPx3). Reference ranges were used as published elsewhere. Asterisks (*) indicate statistical significance. BL baseline, GFR glomerular filtration rate, ICU intensive care unit

Back to article page